STAGE III NON-SMALL-CELL LUNG CANCER
Clinical trials for STAGE III NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE III NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE III NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer combo aims to boost treatment success
Disease control Recruiting nowThis study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. It combines a smaller, faster radiation field with standard chemo and a follow-up immunotherapy drug called durvalumab. About 110 adults will be randomly assigned to …
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Blood test may guide smarter lung cancer therapy
Disease control Recruiting nowThis study tests whether a blood test (ctDNA) can help doctors decide if adding chemotherapy to the immunotherapy drug cemiplimab improves survival in people with advanced non-small cell lung cancer. About 63 adults with stage IV or stage IIIB/C lung cancer that has not been trea…
Matched conditions: STAGE III NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 19, 2026 11:59 UTC